These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25187794)

  • 1. Immunohistochemical study of nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 in invasive breast carcinoma of no special type.
    Symonowicz K; Duś-Szachniewicz K; Woźniak M; Murawski M; Kołodziej P; Osiecka B; Jurczyszyn K; Ziółkowski P
    Exp Ther Med; 2014 Oct; 8(4):1039-1046. PubMed ID: 25187794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucinous Breast Carcinoma: Clinicopathological Comparison With Invasive Ductal Carcinoma.
    Hashmi AA; Zia S; Yaqeen SR; Ahmed O; Asghar IA; Islam S; Afzal A; Irfan M; Zia F; Ali J
    Cureus; 2021 Mar; 13(3):e13650. PubMed ID: 33824803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint detection of multiple immunohistochemical indices and clinical significance in breast cancer.
    Qiao EQ; Ji M; Wu J; Li J; Xu X; Ma R; Zhang X; He Y; Zha Q; Song X; Zhu L; Tang JH
    Mol Clin Oncol; 2013 Jul; 1(4):703-710. PubMed ID: 24649232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics of metaplastic breast cancer - analysis of the basic immunohistochemical profile and comparison with other invasive breast cancer types.
    Budzik MP; Patera J; Sobol M; Czerw AI; Deptała A; Badowska-Kozakiewicz AM
    Breast; 2019 Feb; 43():135-141. PubMed ID: 30553188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
    Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
    Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 overexpression associates with favourable prognostic factors in invasive breast carcinoma.
    El-Hafez AA; El Aaty Shawky A; Hasan B
    Cancer Biomark; 2012; 12(4):149-54. PubMed ID: 23568005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and Progesterone Receptor Expression in Breast Carcinoma and Its Association With Clinicopathological Variables Among the Pakistani Population.
    Sohail SK; Sarfraz R; Imran M; Kamran M; Qamar S
    Cureus; 2020 Aug; 12(8):e9751. PubMed ID: 32944466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma.
    Pillay K; McCleod H; Chetty R; Hall P
    World J Surg Oncol; 2011 Mar; 9():31. PubMed ID: 21410943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of the HLDF differentiation factor on the production of cytokines by bio-tissues of breast tissue in its non-malignant diseases and in invasive carcinoma of a non-specific type].
    Autenshlyus AI; Studenikina AA; Mikhaylova YS; Proskura AV; Varaksin NA; Sidorov SV; Bogachuk AP; Lipkin VM; Lyakhovich VV
    Biomed Khim; 2020 Nov; 66(6):485-493. PubMed ID: 33372907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of nuclear grade and immunohistochemical features in situ and invasive components of ductal carcinoma of breast.
    Aguiar FN; Mendes HN; Bacchi CE; Carvalho FM
    Rev Bras Ginecol Obstet; 2013 Mar; 35(3):97-102. PubMed ID: 23538467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Hypoxia-Inducible Factor 1α in Invasive Breast Cancer with Metastasis to Lymph Nodes: Correlation with Steroid Receptors, HER2 and EPO-R.
    Badowska-Kozakiewicz A; Sobol M; Patera J
    Adv Clin Exp Med; 2016; 25(4):741-50. PubMed ID: 27629849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NUCKS1 overexpression is a novel biomarker for recurrence-free survival in cervical squamous cell carcinoma.
    Gu L; Xia B; Zhong L; Ma Y; Liu L; Yang L; Lou G
    Tumour Biol; 2014 Aug; 35(8):7831-6. PubMed ID: 24819170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women.
    Badowska-Kozakiewicz AM; Sobol M; Patera J; Kozłowski W
    Arch Med Sci; 2013 Jun; 9(3):466-71. PubMed ID: 23847668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic values of grading system for lymph vessel tumor emboli in patients with invasive breast carcinomas of no special type].
    Yue M; Li F; Deng HY; Zhang LL; Liu YP
    Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):754-758. PubMed ID: 29061019
    [No Abstract]   [Full Text] [Related]  

  • 16. NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway.
    Huang YK; Kang WM; Ma ZQ; Liu YQ; Zhou L; Yu JC
    Carcinogenesis; 2019 Apr; 40(2):370-379. PubMed ID: 30371738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
    Tsutsumi Y
    Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal Receptor, Human Epidermal Growth Factor and Its Association with Breast Cancer Tumor Characteristics in Albania.
    Pajenga E; Rexha T; Çeliku S; Ugrinska A; Bejtja G
    Cent Eur J Public Health; 2016 Sep; 24(3):171-175. PubMed ID: 27760283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of estrogen receptor, progesterone receptor, and human epithelial growth factor receptor 2 in breast cancer and the significance thereof: analysis of 910 cases].
    Liu RB; Zhou XH; Wang JN; Liang HZ; Li XX; Wu ZH; Ye JL; Wang SM
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3397-400. PubMed ID: 19159568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.